Client PortalSchedule a Call

Through December 2025, our website is being updated to reflect our revised service offerings, new resources & availability - check back to see what's new!

Client PortalSchedule a Call

Through December 2025, our website is being updated to reflect our revised service offerings, new resources & availability - check back to see what's new!

Image placeholder

Where Medtech Exits Create Lasting Value

Expert guidance for founders and Boards navigating strategic exits that benefit every stakeholder — including patients.

Explore Your Exit Roadmap

Considering an M&A early exit for your medical device startup?

Exiting a medtech company is rarely just a transaction. It’s the culmination of years of development, collaboration, and trust.

At Medtech M&A Advisors, we help founders, physician-inventors, and Boards plan and execute early exits that align the right partners for a durable transaction that's optimized for all stakeholders.
Our approach is discreet, analytical, and partnership-driven. We understand the science, the strategy, and the human side of every deal.

Amanda determined our medical device exit strategy and executed it skillfully to a successful outcome. As an investor, significant return on your investment is far from guaranteed but Amanda's ability to see the big picture, rally influential champions to our cause, and compel and negotiate with strategic acquirers resulting in a rewarding exit.
I wouldn't hesitate to recommend her to any medical device startup contemplating an early exit.

Rob Swart, Board Director & Investor

Why Founders & Boards Work With Us

Independent. Experienced. Outcome-focused.

We specialize in smaller, complex medtech deals that traditional bankers overlook — helping startups with limited runway or early clinical traction find the right acquirer and achieve dignified, value-building exits.

icon

Fundraising has stalled or diluted 

When the end of your financial runway is fast approaching, an early exit may well be your best strategy to realize return on your investment.

icon

Strategic fit is identified

Timing is crucial in medtech M&A and savvy medical device executives keep a keen eye out for prospective acquirers and windows of opportunity.

icon

Milestones present exit triggers

Meeting a development milestone is cause for celebration and can often be an ideal time to pass the baton to an acquirer who can make it shine.

icon

Need for clarity on exit feasibility

Accelerate your path to LOI with our proven strategies to attract buyers and achieve your best deal terms.

Who We Work With

Our ideal clients are medtech startups and SMBs that often fall outside the typical target profile. Pre-commercial Class I/II medical and assistive devices are our sweet spot for transformative ROIs.

<$25M Exit Deal Value

Lower-middle market; < $25M anticipated deal value, upfront cash & earn-outs inclusive.

≥POC Class I/II Device

FDA Class I or II devices at the Proof of Concept stage or later are a strong fit.

Solid IP Maintenance

Industry standard process, documentation & patents are sellable intellectual properties.

Privately Held Startup or SME

A clear cap table with shareholders on board to execute an exit is a must.

As an industrial designer, I've worked with Amanda on several M&A exit projects and can attest to the accuracy of her insights into the market and potential acquirers and how that should inform initial product development or subsequent tweaks. 
She recognizes that medical device startups operate on limited budgets and works well with technical teams to get the technology to just where it needs to be to attract buyer interest.

Ryan Lee, Industrial Designer

Services We Provide

Early Exit Assessment

An independent, buyer-informed assessment to help founders, boards, and investors determine whether an early exit may be viable and what timing and factors will impact a successful outcome.
Perfect for:Founders and boards who want an independent, accurate assessment to inform next steps.

Learn More

Early Exit Roadmap

A structured, execution-ready plan for positioning your company for an early M&A exit when you're confident that's your next best step.It can be initiated on its own or after the Early Exit Assessment service.
Perfect for:Teams that want a clear, buyer-aligned plan to prepare for an early exit that yields optimal success.

Learn More

Deal Lead Service

Hands-on leadership of a discreet, targeted exit process — from buyer outreach through deal execution. Sophisticated strategy aligned with early-stage medtech realities produce your best odds of success.
Perfect for:Companies ready to pursue an early exit and want experienced deal leadership to handle the process.

learn more

A Note for Physician-Inventors


If you’ve advanced your innovation to the point where it deserves the right strategic partner, we can help you evaluate exit options that preserve both your intent and your intellectual legacy.
Our approach emphasizes alignment — ensuring your technology reaches the patients it was designed to help, through the right acquirer, at the right time.

Explore Your Exit Options

INVESTORS

We work with venture capital and private equity firms seeking to preserve or accelerate value across their medtech portfolios.

LEARN MORE

The Success Story That Started It All

Ready to start a confidential discussion?

Let’s talk about where you are, what’s possible, and how to position your next move.

Articles

Newsletter: Small Ball Strategies for Medtech Early Exits Via M&A

Strategies, tactics, and tips to help you lead your medical device startup or SMB to a successful, profitable, and durable equity/asset sale or partnership